INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹36 Cr | ₹36 Cr | ₹34 Cr | ₹33 Cr | ₹32 Cr |
What is the latest Long Term Provisions ratio of INDOCO REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹36 Cr |
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹32 Cr |
How is Long Term Provisions of INDOCO REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹36 Cr | -0.47 | |
| Mar2025 | ₹36 Cr | 6.35 | |
| Mar2024 | ₹34 Cr | 0.86 | |
| Mar2023 | ₹33 Cr | 5.20 | |
| Mar2022 | ₹32 Cr | - | |
Compare Long Term Provisions of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,936.0 Cr | -7.7% | -15.8% | -24.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -7.7% |
-15.8% |
-24.2% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses